U.S. Medical Equipment Stock News

In recent months, Brady Corporation reported solid quarterly results, with five-year compounded annual revenue growth of 7.5% and earnings per share increasing 15.7% annually. These figures highlight that Brady’s offerings continue to appeal to customers even as its core organic revenue growth slowed to 1.6% over the past two years. While strong long-term sales and earnings trends underscore the effectiveness of Brady’s product portfolio and execution, the recent slowdown in organic growth...

STAAR Surgical recently reshaped its board after shareholders rejected a proposed merger with Alcon, adding three investor-affiliated directors while CEO Stephen Farrell stepped down from the board but remains in the role until January 31, 2026. This shift hands greater influence to major shareholder Broadwood Partners and its allies, signaling potential changes in governance priorities and capital allocation for the standalone company. With Broadwood-backed directors now on the board, we’ll...

If you are wondering whether Easterly Government Properties is attractively priced or not, you are in the right place. This article is built around helping you make sense of what the current share price might imply. The stock last closed at US$22.87, with returns of 1.1% over the past week, 2.7% over the past month, a 7.3% gain year to date, and declines of 13.2% over 1 year, 24.4% over 3 years, and 43.5% over 5 years. This can signal shifting views on both its potential and its...

H.B. Fuller FY 2025 earnings snapshot H.B. Fuller (FUL) has wrapped up FY 2025 with fourth quarter revenue of US$894.8 million and basic EPS of US$0.55, setting the tone for a year where earnings momentum and margin progression were in focus for investors. The company has seen quarterly revenue move from US$917.9 million in Q3 2024 to the US$788.7 million to US$898.1 million range across the first three quarters of 2025, while basic EPS shifted from US$1.01 in Q3 2024 to US$0.24, US$0.77 and...

Lemonade recently reported past quarterly results showing improving profitability metrics, including a steadily declining gross loss ratio and positive adjusted free cash flow, alongside strong growth in in-force premiums. These efficiency gains suggest Lemonade’s AI-driven underwriting and claims systems are materially improving how much of each premium dollar the company keeps. We’ll now examine how Lemonade’s improving gross loss ratio reshapes its existing investment narrative and what...

If you are wondering whether Planet Labs PBC is still reasonably priced after its recent run, this article walks through what the current share price might be implying about the business. The stock closed at US$28.28, with returns of 26.0% over 7 days, 58.2% over 30 days, 38.6% year to date, and a very large gain over 1 year that is more than 7x. Recent coverage has focused on Planet Labs PBC's role in satellite powered Earth observation and how its data products are being used across areas...

In the past few days, Grabar Law Office began investigating Molina Healthcare over alleged failures to disclose key medical cost and guidance-related risks, including assumptions about cost trends, premium–cost alignment, and potential cuts to fiscal year 2025 guidance. This investigation raises fresh questions about how accurately Molina’s internal expectations around medical utilization and pricing were communicated to shareholders, and how resilient its business model is to those...

Krystal Biotech (KRYS) has drawn fresh attention after recent trading left the stock with a 1 day return of 3.35% and a past 3 months return of 48.25%, prompting investors to reassess its profile. See our latest analysis for Krystal Biotech. That move comes on top of a 13.3% 7 day share price return, an 18.2% 30 day share price return, and a 48.3% 90 day share price return. The 1 year total shareholder return of 94.7% and 3 year total shareholder return above 2.5x suggest strong momentum has...

In early January 2026, Hancock Whitney Corporation elevated long-time executive Emory Mayfield to Chief Banking Officer and hired Devon Bray as executive vice president and director of Business Banking and SBA, tasking them with overseeing core banking lines and sharpening the bank’s business banking and digital capabilities. These leadership changes arrive just ahead of Hancock Whitney’s upcoming quarterly earnings release, focusing investor attention on how a refreshed banking team may...

Mind Medicine (MindMed) (DFTX) is rebranding to Deinium Therapeutics and switching its Nasdaq ticker from MNMD to DFTX on January 15, 2026, drawing fresh attention to its psychiatry focused pipeline. See our latest analysis for Mind Medicine (MindMed). The rebrand to Deinium Therapeutics and new DFTX ticker come after a period of strong momentum, with a 30 day share price return of 25.45% and a 1 year total shareholder return of 136.25%, although the 5 year total shareholder return remains a...

If you are wondering whether Enphase Energy is a bargain or a value trap at its current price, the key is to understand what the recent numbers actually say about the stock. The share price closed at US$35.36, with returns of 11.0% over 30 days and 4.8% year to date, but also a 44.3% decline over 1 year and an 84.1% decline over 3 years. Recent news around Enphase has focused on the broader solar and clean energy sector, including investor debates about demand for residential solar equipment...

News (NWSA) is back in focus after agreeing to deploy Symbolic.ai’s publishing platform inside Dow Jones Newswires. The move highlights management’s push to weave artificial intelligence more deeply into its financial news operations. See our latest analysis for News. At a share price of US$26.70, News has seen a 3.1% 30 day share price return and a 46.5% three year total shareholder return. The 1 year total shareholder return of a 2.2% decline suggests momentum has cooled, even as management...

If you are wondering whether Albertsons Companies stock offers good value at today’s price, you are not alone. This article is built to help you frame that question clearly before you make any decisions. The share price closed at US$17.38 recently, with returns of 4.5% over the last 7 days, a 0.5% decline over 30 days, a 0.4% gain year to date, and an 11.4% decline over 1 year, while the 5 year return sits at 49.3%. These mixed returns have kept Albertsons on many watchlists, as investors...

If you have been wondering whether Omnicom Group's share price still reflects its underlying business, this article walks through what the current numbers actually say about value. The stock last closed at US$80.84, with returns of 2.6% over the past 7 days, 0.2% over the past 30 days, a 0.6% decline year to date and a 2.3% decline over the past year. This is set against gains of 8.8% over 3 years and 52.6% over 5 years. Recent coverage has focused on how global advertising and marketing...

If you are wondering whether Booking Holdings at around US$5,193 per share still offers value, you are not alone. Many investors are rechecking what a fair price looks like for this travel heavyweight. The stock is currently showing a 4.6% decline over 7 days, a 4.5% decline over 30 days, is down 2.4% year to date, yet is up 7.5% over 1 year and has a very large 3 year and 5 year return that can matter for how you think about risk and potential reward. Recent news coverage around Booking...

Why AIRO Group Holdings (AIRO) Is Back on Investors’ Radar Recent coverage around AIRO Group Holdings (AIRO) has zeroed in on its liquidity position and upcoming execution milestones, which together help explain the renewed interest you might be seeing in the stock. See our latest analysis for AIRO Group Holdings. After a sharp 71.65% 30 day share price return and a 42.86% year to date share price return, AIRO’s recent pullback, including a 24.57% 90 day share price decline and softer 1 day...

If you are wondering whether Northern Trust, at around US$147 a share, is offering fair value or a potential bargain, this article walks you through the numbers in plain English. The stock has returned 1.9% over the past week, 6.4% over the last 30 days, 5.6% year to date, 41.9% over 1 year, 79.4% over 3 years and 81.8% over 5 years, which raises fair questions about what is already priced in. Recent coverage of the US financial sector has kept established custody and asset servicing banks...

If you are wondering whether L3Harris Technologies at US$340.42 is offering fair value right now, you are not alone. This article walks through what the current price might be implying. The stock has returned 4.5% over the last 7 days, 20.4% over 30 days, 11.8% year to date, 58.8% over 1 year, 89.5% over 3 years, and 105.8% over 5 years. These figures raise questions about how much of the story is already reflected in the share price. Recent attention on defense and aerospace contractors has...

This article considers whether PDD Holdings, at around US$107 per share, is priced for opportunity or already reflects its current story by examining what the market price may be implying about its value. The stock has had a mixed run, with a 7.1% return over the past year and longer-term 3-year returns of 19.1%. However, a 7.2% decline year to date and an 11.7% fall over the last week hint at shifting sentiment and changing perceptions of risk. Recent attention on PDD Holdings has centered...

PENN Entertainment (PENN) has unveiled a new corporate structure that reshapes leadership, places more technology responsibility under its Interactive unit, and targets a tighter link between digital products and its retail casino network. See our latest analysis for PENN Entertainment. The restructuring news comes after a mixed year for investors, with the 1 year total shareholder return showing a 28.74% loss and the 5 year total shareholder return down 86.40%. At the same time, the share...

If you are wondering whether Mercury Systems' recent share price strength still leaves any value on the table, this breakdown is designed to help you weigh the upside against the risks. The stock last closed at US$102.95, with returns of 16.0% over 7 days, 43.4% over 30 days, 35.4% year to date, 140.2% over 1 year and 119.4% over 3 years, which naturally raises questions about how the current price lines up with underlying value. These moves have played out alongside ongoing investor...

In early January 2026, Axon Vision announced it had received an order from Leonardo DRS for new AI-enabled counter-unmanned aerial systems to support U.S. defense and homeland security forces, with the systems set for operational evaluations across manned and unmanned platforms. These AI-based counter-drone systems deepen the cooperation between Leonardo DRS and Axon Vision, highlighting Leonardo DRS’s push to pair its advanced sensing and integration capabilities with third-party...

Recent progress in robotaxi partnerships and new market entries has put Lyft (LYFT) back in focus, as investors weigh autonomous ambitions against a flat share price over the past 3 months and strong free cash flow. See our latest analysis for Lyft. Those robotaxi partnerships and international pushes sit against a mixed share price picture, with the latest close at US$18.88, a 1 year total shareholder return of 38.82% and a 5 year total shareholder return of a 60.75% decline. This suggests...

Investors may be asking whether SEI Investments is fairly priced at its recent levels, or if the market is overlooking something in plain sight. The stock last closed at US$86.54, with a 0.8% decline over 7 days, a 4.3% return over 30 days and year to date, and a 5.6% return over the past year. The 3-year and 5-year returns are 48.0% and 54.6% respectively. Recent price moves are drawing fresh attention to how SEI Investments is positioning itself in the broader diversified financials space...